Simplex Trading’s Niagen Bioscience NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $185K | Sell |
42,000
-1,100
| -3% | -$5.94K | ﹤0.01% | 4393 |
|
|
2025
Q4 | $274K | Sell |
43,100
-3,900
| -8% | -$27.1K | ﹤0.01% | 3911 |
|
|
2025
Q3 | $438K | Buy |
47,000
+34,500
| +276% | +$348K | ﹤0.01% | 3984 |
|
|
2025
Q2 | $180K | Buy |
12,500
+700
| +6% | +$6.91K | ﹤0.01% | 4627 |
|
|
2025
Q1 | $81K | Sell |
11,800
-15,500
| -57% | -$97.4K | ﹤0.01% | 5289 |
|
|
2024
Q4 | $144K | Buy |
27,300
+3,200
| +13% | +$17.5K | ﹤0.01% | 4831 |
|
|
2024
Q3 | $87K | Sell |
24,100
-2,500
| -9% | -$7.87K | ﹤0.01% | 5381 |
|
|
2024
Q2 | $72K | Sell |
26,600
-5,100
| -16% | -$17.1K | ﹤0.01% | 5717 |
|
|
2024
Q1 | $110K | Buy |
+31,700
| New | +$58.7K | ﹤0.01% | 5489 |
|
|
2023
Q4 | – | Sell |
-3,500
| Closed | -$5K | – | 10046 |
|
|
2023
Q3 | $5K | Sell |
3,500
-100
| -3% | -$156 | ﹤0.01% | 7706 |
|
|
2023
Q2 | $5K | Sell |
3,600
-5,900
| -62% | -$8.8K | ﹤0.01% | 7976 |
|
|
2023
Q1 | $14K | Buy |
9,500
+2,600
| +38% | +$4.63K | ﹤0.01% | 7275 |
|
|
2022
Q4 | $11K | Buy |
6,900
+5,800
| +527% | +$9.2K | ﹤0.01% | 7486 |
|
|
2022
Q3 | $1K | Buy |
1,100
+400
| +57% | +$644 | ﹤0.01% | 9696 |
|
|
2022
Q2 | $1K | Sell |
700
-1,200
| -63% | -$2.35K | ﹤0.01% | 9717 |
|
|
2022
Q1 | $4K | Sell |
1,900
-2,900
| -60% | -$7.92K | ﹤0.01% | 9612 |
|
|
2021
Q4 | $17K | Sell |
4,800
-43,200
| -90% | -$233K | ﹤0.01% | 8576 |
|
|
2021
Q3 | $470K | Buy |
48,000
+200
| +0.4% | +$1.65K | ﹤0.01% | 4190 |
|
|
2021
Q2 | $471K | Buy |
47,800
+47,171
| +7,499% | +$411K | ﹤0.01% | 4258 |
|
|
2021
Q1 | $587K | Buy |
629
+533
| +555% | +$4.22K | ﹤0.01% | 3144 |
|
|
2020
Q4 | $46K | Buy |
+96
| New | +$468 | ﹤0.01% | 6285 |
|
|
2020
Q2 | – | Sell |
-4
| Closed | -$1K | – | 8531 |
|
|
2020
Q1 | $1K | Buy |
+4
| New | +$15 | ﹤0.01% | 7429 |
|
|
2019
Q2 | – | Sell |
-35
| Closed | -$14K | – | 7940 |
|
|
2019
Q1 | $14K | Buy |
+35
| New | +$126 | ﹤0.01% | 5961 |
|
|
2018
Q3 | – | Sell |
-18
| Closed | -$6K | – | 8200 |
|
|
2018
Q2 | $6K | Sell |
18
-30
| -63% | -$114 | ﹤0.01% | 6645 |
|
|
2018
Q1 | $8K | Sell |
48
-3
| -6% | -$16 | ﹤0.01% | 4249 |
|
|
2017
Q4 | $17K | Buy |
+51
| New | +$275 | ﹤0.01% | 3463 |
|
|
2017
Q3 | – | Sell |
-10
| Closed | -$1K | – | 6794 |
|
|
2017
Q2 | $1K | Buy |
+10
| New | +$32 | ﹤0.01% | 5784 |
|
Other funds holding NAGE
SW
VCM
TCM
Simplex Trading's NAGE Position: Q1 2026 in Review
Simplex Trading increased its Niagen Bioscience (NAGE) stake by 8.2% in Q1 2026, buying an estimated $10.9K and bringing the position to 26,677 shares worth $118K. The position accounts for ﹤0.01% of the portfolio, ranked #4897.
Simplex Trading first reported a position in NAGE in Q2 2016 and has held it in 22 quarters since. The position peaked at $227K in Q3 2025. 143 funds tracked by Wall St. Rank hold NAGE as of Q1 2026.
- Simplex Trading held 26,677 shares of Niagen Bioscience worth $118K as of Q1 2026.
- Simplex Trading bought 2,015 Niagen Bioscience shares in Q1 2026, an estimated $10.9K.
- Niagen Bioscience made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4897 holding.
- Simplex Trading first reported a position in Niagen Bioscience in Q2 2016 and has held it in 22 quarters since.
- Simplex Trading's Niagen Bioscience position peaked at $227K in Q3 2025.
- 143 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.